Q2 FY2026 · ended Jun 30, 2026 · Revenue $64.08M, +47.6% YoY · Filed Aug 13, 2026
Heartflow, Inc. (HTFL) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $64.1 million and a net loss of $15.7 million. Free cash flow was -$10.5 million. As of Jun 30, 2026 it held $246.8 million in cash and investments and $27.1 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- HTFL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Francisco, CA
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1464521
- Former names
- Cardiovascular Simulation, Inc. (until Jun 14, 2010)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $64.1M | $52.6M | $49.1M | $46.3M | $43.4M |
| Operating income | -$17.9M | -$29.5M | -$17.8M | -$15.1M | -$13.7M |
| Net income | -$15.7M | -$27.4M | -$24.4M | -$50.9M | -$9.2M |
| Diluted EPS | -$0.18 | -$0.32 | -$0.29 | -$1.04 | -$1.46 |
| Operating cash flow | -$8.6M | -$30.1M | -$10.6M | -$3.0M | -$40.5M |
| Free cash flow | -$10.5M | -$32.0M | -$12.5M | -$4.2M | -$42.4M |
| Total assets | $344.5M | $344.0M | $359.5M | $364.4M | $159.4M |
| Total liabilities | $64.7M | $58.3M | $58.8M | $109.8M | $285.6M |
| Stockholders' equity | $279.7M | $285.7M | $300.6M | $254.6M | -$894.8M |
| Cash and investments | $246.8M | $254.9M | $280.2M | $291.2M | $80.2M |
| Total debt | $27.1M | $26.3M | $22.1M | $21.8M | $22.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 16, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
All 194 Heartflow, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.